Hillis, G. S. et al. (2014) The Relative and Combined Ability of High-Sensitivity Cardiac Troponin T and N-Terminal Pro-B-Type Natriuretic Peptide to Predict Cardiovascular Events and Death in Patients With Type 2 Diabetes. Diabetes Care, 37(1), pp. 295-303. (doi: 10.2337/dc13-1165)

Goya Wannamethee, S., Welsh, P. , Whincup, P. H., Lennon, L., Papacosta, O. and Sattar, N. (2014) N-terminal pro brain natriuretic peptide but not copeptin improves prediction of heart failure over other routine clinical risk parameters in older men with and without cardiovascular disease: population-based study. European Journal of Heart Failure, 16(1), pp. 25-32. (doi: 10.1093/eurjhf/hft124)

Mirjafari, H. et al. (2014) N-terminal pro-brain-type natriuretic peptide (NT-pro-BNP) and mortality risk in early inflammatory polyarthritis: results from the Norfolk Arthritis Registry (NOAR). Annals of the Rheumatic Diseases, 73(4), pp. 684-690. (doi: 10.1136/annrheumdis-2012-202848)

Feinkohl, I. et al. (2013) Clinical and subclinical macrovascular disease as predictors of cognitive decline in older patients with type 2 diabetes: the Edinburgh type 2 diabetes study. Diabetes Care, 36(9), pp. 2779-2786. (doi: 10.2337/dc12-2241)

Welsh, P. , Doolin, O., Willeit, P., Packard, C. , Macfarlane, P., Cobbe, S., Gudnason, V., Di Angelantonio, E., Ford, I. and Sattar, N. (2013) N-terminal pro-B-type natriuretic peptide and the prediction of primary cardiovascular events: results from 15-year follow-up of WOSCOPS. European Heart Journal, 34(6), pp. 443-450. (doi: 10.1093/eurheartj/ehs239)

Welsh, P. et al. (2012) Circulating 250HD, dietary vitamin D, PTH, and calcium associations with incident cardiovascular disease and mortality: The MIDSPAN Family Study. Journal of Clinical Endocrinology and Metabolism, 97(12), pp. 4578-4587. (doi: 10.1210/jc.2012-2272)

Feinkohl, I., Sattar, N. , Welsh, P. , Reynolds, R. M., Deary, I. J., Strachan, M. W.J. and Price, J. F. (2012) Association of N-terminal pro-brain natriuretic peptide with cognitive function and depression in elderly people with type 2 diabetes. PLoS ONE, 7(9), e44569. (doi: 10.1371/journal.pone.0044569) (PMID:22973461) (PMCID:PMC3433429)

Preiss, D. et al. (2012) Lipid-modifying therapies and risk of pancreatitis: a meta-analysis. JAMA: Journal of the American Medical Association, 308(8), pp. 804-811. (doi: 10.1001/jama.2012.8439)

Welsh, P. and McMurray, J.J. (2012) B-type natriuretic peptide and glycaemia: an emerging cardiometabolic pathway? Diabetologia, 55(5), pp. 1240-1243. (doi: 10.1007/s00125-012-2515-3)

Sever, P. S., Poulter, N. R., Chang, C. L., Hingorani, A., Thom, S. A., Hughes, A. D., Welsh, P. and Sattar, N. (2012) Evaluation of C-reactive protein prior to and on-treatment as a predictor of benefit from atorvastatin: observations from the Anglo-Scandinavian Cardiac Outcomes Trial. European Heart Journal, 33(4), pp. 486-494. (doi: 10.1093/eurheartj/ehr262)

Sattar, N. , Welsh, P. , Panarelli, M. and Forouhi, N. G. . (2012) Increasing requests for vitamin D measurement: costly, confusing, and without credibility. Lancet, 379(9811), pp. 95-96. (doi: 10.1016/S0140-6736(11)61816-3)

Goldenberg, D., Miller, E., Perna, M., Sattar, N. , Welsh, P. , Roman, M. J. and Salmon, J. E. (2012) Association of N-terminal pro-brain natriuretic peptide with cardiac disease, but not with vascular disease, in systemic lupus erythematosus. Arthritis and Rheumatism, 64(1), pp. 316-317. (doi: 10.1002/art.33374)

Pfister, R. et al. (2011) Mendelian randomization study of B-type natriuretic peptide and type 2 diabetes: evidence of causal association from population studies. PLoS Medicine, 8(10), e1001112. (doi: 10.1371/journal.pmed.1001112)

Welsh, P. et al. (2011) Circulating interleukin-10 and risk of cardiovascular events: a prospective study in the elderly at risk. Arteriosclerosis, Thrombosis, and Vascular Biology, 31(10), pp. 2338-2344. (doi: 10.1161/ATVBAHA.111.231795) (PMID:21757655)

Wannamethee, S. G., Welsh, P. , Lowe, G. D., Gudnason, V., Di Angelantonio, E., Lennon, L., Rumley, A., Whincup, P. H. and Sattar, N. (2011) N-terminal pro-brain natriuretic peptide is a more useful predictor of cardiovascular disease risk than C-reactive protein in older men with and without pre-existing cardiovascular disease. Journal of the American College of Cardiology, 58(1), pp. 56-64. (doi: 10.1016/j.jacc.2011.02.041)